In June 2026, a US customer could buy a salted caramel coffee-flavoured protein powder made with Solein, an ingredient produced in Finland by Solar Foods. The manufacturer described the launch by Ambrosia Collective as a market test. For a first factory, the launch showed that someone had taken the ingredient through formulation, packaging and a saleable product. Anyone financing production still needed to know when that customer would need the next batch and how much it would order. Solar Foods on the June test launch
The financing case for a food-biotech factory depends on how many kilos the factory can make to the required specification, how many a customer will accept, and how much cash the company needs until the customer pays for those kilos. An installed production line, an order from a brand and repeat consumer demand are each evidence of something different.
Put the factory’s calendar beside the customer’s
Factory 01 started operating in April 2024. In October 2025, after a summer maintenance break, Solar Foods said it had reached the operating parameters for its design capacity of 160 tonnes annually. In January 2026 it announced an order from Ambrosia Collective. The US retail test followed in June. All four dates come from Solar Foods’ own announcements. Annual design capacity does not tell us the tonnes manufactured or sold over a year. An order announcement tells us little about payment timing or subsequent demand. Factory 01 productivity update · Ambrosia order announcement
The online launch established that a customer had listed the finished product for sale. Before adding a second shift, a board needs to know how quickly the stock sells, when the customer reorders and which volumes it will commit to in writing. A supplier may have the first two answers and still be negotiating the third.
Count the kilos a buyer can use
Consider a hypothetical production run containing 1,000 kg of target ingredient, measured on the same dry-mass basis as the final product. At 80% recovery, 800 kg reaches final testing. Suppose 50 kg of that output misses the customer’s specification and cannot be reworked or sold. The customer can use 750 kg. At a common price per kilo, a forecast booking all 1,000 kg overstates the sales available from that run by 250 kg, a quarter of the modelled quantity. These numbers illustrate the calculation. They are independent of Solar Foods and do not represent typical industry yields. GFI on fermentation production and recovery
Now place yourself at the other end of the transaction. A brand buying an ingredient for a drink may have to assess the result in its own recipe, on its own line and after storage. Ask which piece of evidence lets its quality team release the batch. Ask too whether a product that passes the supplier’s tests would need another application trial. The answers belong to the people responsible for the product on the shelf.
| Entry in the factory forecast | Evidence to put beside it |
|---|---|
| Saleable kilograms | Representative output, recovery and the share passing the agreed specification. Identify which values were measured and which remain targets. |
| Earliest lawful sale in the chosen market | The regulatory owner’s confirmation of product identity, intended use, jurisdiction and applicable authorisation. |
| First invoice and date due | The customer’s order, acceptance conditions, sign-off authority and payment terms. |
| Repeat monthly volume | Reorder history or a purchase obligation the buyer has accepted. Mark voluntary forecasts as forecasts. |
For an EU sale, establish whether the novel-food procedure applies. EFSA assesses safety where required. The subsequent authorisation process and permitted uses matter to the sales case. On the 9th of November 2026, Solar Foods reported a positive EFSA scientific opinion for Solein. Final EU authorisation still rests with the European Commission. The company said the opinion lets it advance offtake negotiations and financing for Factory 02. A retail launch in one country cannot establish permission in another. Check the Swiss route separately for a Swiss sale. EFSA novel-food application procedure · Solar Foods EFSA announcement · Swiss novel-food authorisation
What would the next round of funding buy?
A manufacturer might be able to rent a production slot and make representative samples before it can commission an owned line. The calculation turns on whether the samples will count. If the buyer requires new qualification after the process transfers, include the extra batch, testing time and cash in the comparison. Ask the manufacturing partner who releases product, who pays for a failed run and whether capacity is reserved when the buyer wants its second delivery.
An owned line might make economic sense at sustained output while losing cash in its first year. Move the date of routine customer approval back a quarter. Retain the people, storage and committed input costs required under that scenario. Then calculate the lowest cash balance, when it occurs, and the additional funds the company can draw by then.
In June 2026, Business Finland approved €77.8 million in grants and loans for Solar Foods’ second factory. Solar Foods reported two conditions. It had to take a final investment decision and secure the total financing. A board looking at the date of the next equipment payment therefore needs to know who will commit the remaining money. It also needs to know whether the company can draw the support in time to pay the supplier. Solar Foods’ half-year report on Factory 02 financing
The part a working room can examine
The Next Food System session at The Decision Room’s first Zürich edition, hosted by Ali Morrow of Clay Capital, recorded two tasks for further work. One was to map debt and blended-capital providers for European scale-up. The other was to gather cases where producers had used side streams from neighbouring industries to reduce input costs. Both start by asking which assumption in a production plan someone else can prove. Read the Edition I record
For Edition II in May 2027, bring a decision you can share without disclosing a recipe or confidential customer terms. A buyer could identify the trial that stands between a sample and a purchase. An operator could identify the batch size that its model assumes will pass. A financier could show which of those uncertainties it has authority to fund. Explore the developing programme
For construction and commissioning across sectors, read the first-of-a-kind plant guide. For a technical, purchasing or finance meeting, compare European food biotechnology events.